Hidetaka Fujinaga

454 citations
12 papers · 243 indexed · h-index 6

Hidetaka Fujinaga

12 papers receiving 236 citations

Peers

Hidetaka Fujinaga
Comparison fields: 5 of 48
  • Hepatology 42
  • Epidemiology 164
  • Endocrinology, Diabetes and Metabolism 73
  • Surgery 114
  • Gastroenterology 13
Replace Takeharu Asano with:
Takeharu Asano Japan
Ryuta Shigefuku Japan
K. Patsiaoura Greece
Pao‐Yuan Huang Taiwan
Philippe Sultanik France
Asmita Pant United States
Takahiro Ozutsumi Japan
Sophia Califano United States
Hossein Nobakht Iran
Federica Benini Italy
Hidetaka Fujinaga relative to Takeharu Asano Japan Takeharu Asano's profile →
Citations per field
00.5×3.8×
Takeharu Asano · 1×
Citations per year

Countries citing papers authored by Hidetaka Fujinaga

Since Specialization
Citations

This map shows the geographic impact of Hidetaka Fujinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetaka Fujinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetaka Fujinaga more than expected).

Fields of papers citing papers by Hidetaka Fujinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetaka Fujinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetaka Fujinaga. The network helps show where Hidetaka Fujinaga may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hidetaka Fujinaga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hidetaka Fujinaga Line = papers co-authored together Hidetaka Fujinaga links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20213
2 202013
3 20204
4 201915
5 201845
6 20172
7 20163
8 201582
9 201552
10 20151
11 200621
12
Systemic lupus erythematosus complicated by disseminated intravascular coagulation: the role of serum soluble cell surface markers.
19982

About Hidetaka Fujinaga

Hidetaka Fujinaga is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 12 papers that have together received 243 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (3 papers), Liver Disease and Transplantation (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Systemic Lupus Erythematosus Research (2 papers), Diet, Metabolism, and Disease (2 papers), Liver Diseases and Immunity (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Hepatology (42 citations), Epidemiology (164 citations) and Endocrinology, Diabetes and Metabolism (73 citations). Hidetaka Fujinaga has collaborated with scholars based in Japan and United States. Frequent co-authors include Kazuhiko Koike, Takeya Tsutsumi, Kyoji Moriya, Kazuya Okushin, Hiroshi Yotsuyanagi, Kenichiro Enooku, Kazuhiko Ikeuchi, Nobutake Yamamichi, Toru Mitsushima and Masashi Fukayama. Their work appears in journals such as PLoS ONE, Journal of Gastroenterology, Journal of Clinical Pathology, Medicine and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026